A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission

Neuron

Volumn 35, Issue 6, 2002, Pages 1111-1122

  Kotecha, Suhas A ^a   Oak, James N ^a,b   Jackson, Michael F ^a   Perez, Yael ^a   Orser, Beverley A ^a   Van Tol, Hubert H M ^a,b   MacDonald, John F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; QUINPIROLE; RECEPTOR SUBTYPE; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; INTRINSIC KINASE ACTIVITY; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSACTIVATION;

EID: 0037068833     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(02)00859-0     Document Type: Article

References (67)

1. 2+ concentration in rat hippocampal neurons. Brain Res. 587:1992;102-108.
2. Arnsten A.F., Murphy B., Merchant K. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology. 23:2000;405-410.
3. Barkley R.A. Attention-deficit hyperactivity disorder. Sci. Am. 279:1998;66-71.
4. Blank T., Nijholt I., Teichert U., Kugler H., Behrsing H., Fienberg A., Greengard P., Spiess J. The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc. Natl. Acad. Sci. USA. 94:1997;14859-14864.
5. Bliss T.V.P., Collingridge G.L. A synaptic model of memory. long-term potentiation in the hippocampus Nature. 361:1993;31-39.
6. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B., Bernardi G., Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17:1997;4536-4544.
7. Castro N.G., de Mello M.C., de Mello F.G., Aracava Y. Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. Br. J. Pharmacol. 126:1999;1847-1855.
8. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:1994;32023-32026.
9. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 379:1996;557-560.
10. Defagot M.C., Falzone T.L., Low M.J., Grandy D.K., Rubinstein M., Antonelli M.C. Quantitative analysis of the dopamine D4 receptor in the mouse brain. J. Neurosci. Res. 59:2000;202-208.
11. Della R.G., Maudsley S., Daaka Y., Lefkowitz R.J., Luttrell L.M. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J. Biol. Chem. 274:1999;13978-13984.
12. Descarries L., Lemay B., Doucet G., Berger B. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience. 21:1987;807-824.
13. Ehlers M.D., Zhang S., Bernhadt J.P., Huganir R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell. 84:1996;745-755.
14. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., Pessah I.N. Xestospongins. potent membrane permeable blockers of the inositol 1,4,5- trisphosphate receptor Neuron. 19:1997;723-733.
15. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat. a combined retrograde tracing and immunohistochemical study Brain Res. 668:1994;71-79.
16. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 20:2000;RC106.
17. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273:1998;1839-1842.
18. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signaling. beyond the G protein paradigm J. Cell Biol. 145:1999;927-932.
19. Harvey J., Balasubramaniam R., Collingridge G.L. Carbachol can potentiate N-methyl-D-aspartate responses in the rat hippocampus by a staurosporine and thapsigargin-insensitive mechanism. Neurosci. Lett. 162:1993;165-168.
20. Heldin C.H., Ostman A., Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta. 1378:1998;F79-F113.
21. 2+ currents and excitability via a novel PLCβ-IP3-calcineurin-signaling cascade. J. Neurosci. 20:2000;8987-8995.
22. Herrlich A., Daub H., Knebel A., Herrlich P., Ullrich A., Schultz G., Gudermann T. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc. Natl. Acad. Sci. USA. 95:1998;8985-8990.
23. Hsu K.S. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. J. Neurophysiol. 76:1996;1887-1895.
24. Huang Y.Y., Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. USA. 92:1995;2446-2450.
25. Huang Y., Lu W., Ali D.W., Pelkey K.A., Pitcher G.M., Lu Y.M., Aoto H., Roder J.C., Sasaki T., Salter M.W., MacDonald J.F. CAKβ/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron. 29:2001;485-496.
26. Inglese J., Luttrell L.M., Iniguez-Lluhi J.A., Touhara K., Koch W.J., Lefkowitz R.J. Functionally active targeting domain of the β-adrenergic receptor kinase. an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase Proc. Natl. Acad. Sci. USA. 91:1994;3637-3641.
27. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine. from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology. 20:1999;201-225.
28. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 267:1995;1658-1662.
29. Kotecha S.A., Eley D.W., Turner R.W. Tissue printed cells from teleost electrosensory and cerebellar structures. J. Comp. Neurol. 386:1997;277-292.
30. Krupp J.J., Vissel B., Thomas C.G., Heinemann S.F., Westbrook G.L. Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors. J. Neurosci. 19:1999;1165-1178.
31. Law-Tho D., Hirsch J.C., Crepel F. Dopamine modulation of synaptic transmission in rat prefrontal cortex. an in vitro electrophysiological study Neurosci. Res. 21:1994;151-160.
32. Lei S., Lu W.Y., Xiong Z.G., Orser B.A., Valenzuela C.F., MacDonald J.F. Platelet-derived growth factor receptor-induced feed-forward inhibition of excitatory transmission between hippocampal pyramidal neurons. J. Biol. Chem. 274:1999;30617-30623.
33. Lewis D.A., Lieberman J.A. Catching up on schizophrenia. Natural history and neurobiology. Neuron. 28:2000;325-334.
34. Lu W.-Y., Xiong Z.-Y., MacDonald J.F. Multiple sites of action of neomycin, Mg2+ and spermine on the NMDA receptors of rat hippocampal CA pyramidal neurones. J. Physiol. 512:1998;29-46.
35. Lu W.-Y., Xiong Z.-G., Lei S., Orser B.A., Dudek E., Browning M.D., MacDonald J.F. G-protein coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci. 2:1999;1-8.
36. Lu W.Y., Jackson M.F., Bai D., Orser B.A., MacDonald J.F. In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors. J. Neurosci. 20:2000;4452-4461.
37. Luttrell L.M., Daaka Y., Lefkowitz R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11:1999;177-183.
38. Malenka R.C., Nicoll R.A. Long-term potentiation - a decade of progress? Science. 285:1999;1870-1874.
39. Man H.Y., Ju W., Ahmadian G., Wang Y.T. Intracellular trafficking of AMPA receptors in synaptic plasticity. Cell. Mol. Life Sci. 57:2000;1526-1534.
40. McBain C.J., Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:1994;723-760.
41. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H., Damask S.P., Little K.Y., Civelli O., Watson S.J. Jr. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology. 10:1994;239-248.
42. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 98:1999;427-436.
43. Nicola S.M., Surmeier J., Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23:2000;185-215.
44. Oak J.N., Oldenhof J., Van Tol H.H. The dopamine D(4) receptor. one decade of research Eur. J. Pharmacol. 405:2000;303-327.
45. Oak J.N., Lavine N., Van Tol H.H. Dopamine D4 and D2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on transactivation of the PDGF receptor. Mol. Pharmacol. 60:2001;92-103.
46. Otani S., Blond O., Desce J.M., Crepel F. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience. 85:1998;669-676.
47. Otmakhova N.A., Lisman J.E. Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region. J. Neurosci. 19:1999;1437-1445.
48. Peavy R.D., Chang M.S., Sanders-Bush E., Conn P.J. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci. 21:2001;9619-9628.
49. Pierce K.L., Maudsley S., Daaka Y., Luttrell L.M., Lefkowitz R.J. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc. Natl. Acad. Sci. USA. 97:2000;1489-1494.
50. Popov N., Pohle W., Schulzeck S., Matthies H. A biochemical and immunohistological study of calmodulin in rat brain structures. J. Hirnforsch. 29:1988;473-480.
51. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
52. Rosenmund C., Westbrook G.L. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron. 10:1993;805-814.
53. Sawutz D.G., Bode D.C., Briggs G.M., Reid J.R., Canniff P., Caldwell L., Faltynek C.R., Miller D., Dunn J.A., de Garavilla L.et al. In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors. Biochem. Pharmacol. 51:1996;1631-1638.
54. Seeman P., Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
55. Seamans J.K., Durstewitz D., Christie B.R., Stevens C.F., Sejnowski T.J. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. USA. 98:2001;301-306.
56. Snyder G.L., Fienberg A.A., Huganir R.L., Greengard P. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18:1998;10297-10303.
57. Swanson J., Castellanos F.X., Murias M., LaHoste G., Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr. Opin. Neurobiol. 8:1998;263-271.
58. Todd R.D., O'Malley K.L. The dopamine receptor DRD4 gene. are duplications distracting? Trends Pharmacol. Sci. 22:2001;55-56.
59. + channel in acutely dissociated rat substantia nigra neurones. Neuropharmacology. 39:2000;191-201.
60. Umemiya M., Raymond L.A. Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. J. Neurophysiol. 78:1997;1248-1255.
61. Valenzuela C.F., Xiong Z., MacDonald J.F., Weiner J.L., Frazier C.J., Dunwiddie T.V., Kazlauskas A., Whiting P.J., Harris R.A. Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function. J. Biol. Chem. 271:1996;16151-16159.
62. Valenzuela C.F., Kazlauskas A., Weiner J.L. Roles of platelet-derived growth factor in the developing and mature nervous systems. Brain Res. Brain Res. Reviews. 24:1997;77-89.
63. Wang L.Y., MacDonald J.F. Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. J. Physiol. 486:1995;83-95.
64. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch. Gen. Psychiatry. 57:2000;907-913.
65. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 45:1999;395-402.
66. Zhang S., Ehlers M.D., Bernhardt J.P., Su C.T., Huganir R.L. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron. 21:1998;443-453.
67. Zheng P., Zhang X.X., Bunney B.S., Shi W.X. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience. 91:1999;527-535.